glucagon agonist retatrutide A phase 2 clinical trial demonstrates that #retatrutide, a triple of the GIP, GLP-1, and receptors, results in up to 82% reduction in liver fat #MASLD @ArunJSanyalVCU retatrutide mechanism triple agonist glp-1

(The usual warnings apply that some people dont tolerate fruits and vegetables well, some dont tolerate milk well, and some could develop a biotin deficiency or digestive troubles when consuming raw egg whites.) In the future, Ill expand on some of these points, and write more about glutathione with an emphasis on human studies

Ampakine CX717 protects against fentanyl-induced respiratory depression and lethal apnea in rats

This depletion occurs because acetaminophen metabolism generates a reactive metabolite (NAPQI) that binds glutathione for neutralization and elimination

USA based production allows for greater consistency and transparency, with each batch monitored to reduce the presence of impurities and to maintain the integrity of the synthesized material

[1] [2] These studies suggest that visceral fat may decrease proportionally during GLP-1-induced weight loss, similar to patterns seen with dietary caloric restriction

If you plan to discontinue, a gradual taper over 4 to 8 weeks (reducing by one dose step every 2 to 4 weeks) is generally preferred over abrupt cessation